Colin Nixon

48PUBLICATIONS
388CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursNanomedicineCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Jul 15, 2026
Multiscale in vivo imaging of tumor evolution using a germline conditional triple-reporter mouse.

|May 06, 2026
Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesis.

|Mar 04, 2026
Vγ1 γδ T cells steer airway macrophages toward a profibrotic response in an autochthonous lung cancer mouse model.

Ximena L Raffo-Iraolagoitia, Amanda J McFarlane, Sarah Laing

|Jan 23, 2026
Steroid-dependent metabolic rewiring reveals novel therapeutic and imaging approaches for glioblastoma.

Maria Francesca Allega, Ruhi Deshmukh, Theresa Hillinger

|Dec 18, 2025
Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation.

Georgios Kanellos, Chiara Giacomelli, Alexander Raven

|Nov 25, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.

Mark White, Megan L Mills, Laura M Millett

Pageof 8

Frequent Collaborators

23 joint publications

Owen J Sansom

13 joint publications

Andrew D Campbell

13 joint publications

Karen Blyth

11 joint publications

Tom Bird